An alpha1-adrenergic receptor-mediated phosphatidylinositol effect in canine cerebral microvessels

In microvessels isolated from canine cerebral cortex, 32Pi is incorporated into phospholipids when incubated in physiological buffer containing [32Pi]orthophosphate. Norepinephrine (NE) selectively increases 32Pi incorporation into phosphatidylinositol (PI) and phosphatidic acid (PA) 60-200% over co...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Molecular pharmacology 1983-07, Vol.24 (1), p.163-167
Hauptverfasser: R J Zeleznikar, Jr, E E Quist, L R Drewes
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 167
container_issue 1
container_start_page 163
container_title Molecular pharmacology
container_volume 24
creator R J Zeleznikar, Jr
E E Quist
L R Drewes
description In microvessels isolated from canine cerebral cortex, 32Pi is incorporated into phospholipids when incubated in physiological buffer containing [32Pi]orthophosphate. Norepinephrine (NE) selectively increases 32Pi incorporation into phosphatidylinositol (PI) and phosphatidic acid (PA) 60-200% over control levels. Half-maximal stimulation of PI labeling is observed with 1 microM NE, whereas maximal stimulation occurs at approximately 100 microM. Alpha 1-adrenergic agonists, phenylephrine and methoxamine, mimic the effects of NE, whereas isoproterenol, a beta-adrenergic receptor agonist, is ineffective. A wide variety of other agents tested had no specific effect on 32Pi incorporation into PI or PA. Prazosin, a selective alpha 1-receptor antagonist, at a concentration of 0.05 microM inhibits 50% of the stimulation due to NE (100 microM), whereas 1 microM yohimbine, an alpha 2-selective antagonist, is required to achieve the same effect. These results demonstrate the existence of an alpha 1-adrenergic receptor-mediated PI effect in isolated canine cerebral microvessels.
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_80538644</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>80538644</sourcerecordid><originalsourceid>FETCH-LOGICAL-h236t-f910b8b3e49f6d38967753354e7292b3dd60cd57253effbe4ffd32379288dc993</originalsourceid><addsrcrecordid>eNotkEtLxDAcxIMo6_r4CEIueivk0aTJcVl8geBFwVtIk3-3kbSpSVfZb29h9zSH-THDzBlaU8FoRSil52hNCJOV0uLrEl2V8k0IrYUiK7SSlAsq6Bq1mxHbOPWWVtZnGCHvgsMZHExzytUAPtgZPJ76VBZqDv4Qw5hKmFPE0HXgZhxG7OwYRsAOMrTZRjwEl9MvlAKx3KCLzsYCtye9Rp9Pjx_bl-rt_fl1u3mresblXHWakla1HGrdSc-Vlk0jOBc1NEyzlnsvifOiYYIvvS3UXec5441mSnmnNb9GD8fcKaefPZTZDKE4iNGOkPbFKCK4knW9gHcncN8uA82Uw2DzwZxOWfz7o9-HXf8XMphleR6sSzHtDobVhhoqOf8HxFVtbQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>80538644</pqid></control><display><type>article</type><title>An alpha1-adrenergic receptor-mediated phosphatidylinositol effect in canine cerebral microvessels</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>R J Zeleznikar, Jr ; E E Quist ; L R Drewes</creator><creatorcontrib>R J Zeleznikar, Jr ; E E Quist ; L R Drewes</creatorcontrib><description>In microvessels isolated from canine cerebral cortex, 32Pi is incorporated into phospholipids when incubated in physiological buffer containing [32Pi]orthophosphate. Norepinephrine (NE) selectively increases 32Pi incorporation into phosphatidylinositol (PI) and phosphatidic acid (PA) 60-200% over control levels. Half-maximal stimulation of PI labeling is observed with 1 microM NE, whereas maximal stimulation occurs at approximately 100 microM. Alpha 1-adrenergic agonists, phenylephrine and methoxamine, mimic the effects of NE, whereas isoproterenol, a beta-adrenergic receptor agonist, is ineffective. A wide variety of other agents tested had no specific effect on 32Pi incorporation into PI or PA. Prazosin, a selective alpha 1-receptor antagonist, at a concentration of 0.05 microM inhibits 50% of the stimulation due to NE (100 microM), whereas 1 microM yohimbine, an alpha 2-selective antagonist, is required to achieve the same effect. These results demonstrate the existence of an alpha 1-adrenergic receptor-mediated PI effect in isolated canine cerebral microvessels.</description><identifier>ISSN: 0026-895X</identifier><identifier>EISSN: 1521-0111</identifier><identifier>PMID: 6135151</identifier><language>eng</language><publisher>United States: American Society for Pharmacology and Experimental Therapeutics</publisher><subject>Adrenergic alpha-Agonists - pharmacology ; Adrenergic alpha-Antagonists - pharmacology ; Animals ; Brain - blood supply ; Capillaries - metabolism ; Dogs ; In Vitro Techniques ; Phosphatidic Acids - metabolism ; Phosphatidylinositols - metabolism ; Receptors, Adrenergic - physiology ; Receptors, Adrenergic, alpha - physiology</subject><ispartof>Molecular pharmacology, 1983-07, Vol.24 (1), p.163-167</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/6135151$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>R J Zeleznikar, Jr</creatorcontrib><creatorcontrib>E E Quist</creatorcontrib><creatorcontrib>L R Drewes</creatorcontrib><title>An alpha1-adrenergic receptor-mediated phosphatidylinositol effect in canine cerebral microvessels</title><title>Molecular pharmacology</title><addtitle>Mol Pharmacol</addtitle><description>In microvessels isolated from canine cerebral cortex, 32Pi is incorporated into phospholipids when incubated in physiological buffer containing [32Pi]orthophosphate. Norepinephrine (NE) selectively increases 32Pi incorporation into phosphatidylinositol (PI) and phosphatidic acid (PA) 60-200% over control levels. Half-maximal stimulation of PI labeling is observed with 1 microM NE, whereas maximal stimulation occurs at approximately 100 microM. Alpha 1-adrenergic agonists, phenylephrine and methoxamine, mimic the effects of NE, whereas isoproterenol, a beta-adrenergic receptor agonist, is ineffective. A wide variety of other agents tested had no specific effect on 32Pi incorporation into PI or PA. Prazosin, a selective alpha 1-receptor antagonist, at a concentration of 0.05 microM inhibits 50% of the stimulation due to NE (100 microM), whereas 1 microM yohimbine, an alpha 2-selective antagonist, is required to achieve the same effect. These results demonstrate the existence of an alpha 1-adrenergic receptor-mediated PI effect in isolated canine cerebral microvessels.</description><subject>Adrenergic alpha-Agonists - pharmacology</subject><subject>Adrenergic alpha-Antagonists - pharmacology</subject><subject>Animals</subject><subject>Brain - blood supply</subject><subject>Capillaries - metabolism</subject><subject>Dogs</subject><subject>In Vitro Techniques</subject><subject>Phosphatidic Acids - metabolism</subject><subject>Phosphatidylinositols - metabolism</subject><subject>Receptors, Adrenergic - physiology</subject><subject>Receptors, Adrenergic, alpha - physiology</subject><issn>0026-895X</issn><issn>1521-0111</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1983</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNotkEtLxDAcxIMo6_r4CEIueivk0aTJcVl8geBFwVtIk3-3kbSpSVfZb29h9zSH-THDzBlaU8FoRSil52hNCJOV0uLrEl2V8k0IrYUiK7SSlAsq6Bq1mxHbOPWWVtZnGCHvgsMZHExzytUAPtgZPJ76VBZqDv4Qw5hKmFPE0HXgZhxG7OwYRsAOMrTZRjwEl9MvlAKx3KCLzsYCtye9Rp9Pjx_bl-rt_fl1u3mresblXHWakla1HGrdSc-Vlk0jOBc1NEyzlnsvifOiYYIvvS3UXec5441mSnmnNb9GD8fcKaefPZTZDKE4iNGOkPbFKCK4knW9gHcncN8uA82Uw2DzwZxOWfz7o9-HXf8XMphleR6sSzHtDobVhhoqOf8HxFVtbQ</recordid><startdate>198307</startdate><enddate>198307</enddate><creator>R J Zeleznikar, Jr</creator><creator>E E Quist</creator><creator>L R Drewes</creator><general>American Society for Pharmacology and Experimental Therapeutics</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>198307</creationdate><title>An alpha1-adrenergic receptor-mediated phosphatidylinositol effect in canine cerebral microvessels</title><author>R J Zeleznikar, Jr ; E E Quist ; L R Drewes</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-h236t-f910b8b3e49f6d38967753354e7292b3dd60cd57253effbe4ffd32379288dc993</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1983</creationdate><topic>Adrenergic alpha-Agonists - pharmacology</topic><topic>Adrenergic alpha-Antagonists - pharmacology</topic><topic>Animals</topic><topic>Brain - blood supply</topic><topic>Capillaries - metabolism</topic><topic>Dogs</topic><topic>In Vitro Techniques</topic><topic>Phosphatidic Acids - metabolism</topic><topic>Phosphatidylinositols - metabolism</topic><topic>Receptors, Adrenergic - physiology</topic><topic>Receptors, Adrenergic, alpha - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>R J Zeleznikar, Jr</creatorcontrib><creatorcontrib>E E Quist</creatorcontrib><creatorcontrib>L R Drewes</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Molecular pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>R J Zeleznikar, Jr</au><au>E E Quist</au><au>L R Drewes</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>An alpha1-adrenergic receptor-mediated phosphatidylinositol effect in canine cerebral microvessels</atitle><jtitle>Molecular pharmacology</jtitle><addtitle>Mol Pharmacol</addtitle><date>1983-07</date><risdate>1983</risdate><volume>24</volume><issue>1</issue><spage>163</spage><epage>167</epage><pages>163-167</pages><issn>0026-895X</issn><eissn>1521-0111</eissn><abstract>In microvessels isolated from canine cerebral cortex, 32Pi is incorporated into phospholipids when incubated in physiological buffer containing [32Pi]orthophosphate. Norepinephrine (NE) selectively increases 32Pi incorporation into phosphatidylinositol (PI) and phosphatidic acid (PA) 60-200% over control levels. Half-maximal stimulation of PI labeling is observed with 1 microM NE, whereas maximal stimulation occurs at approximately 100 microM. Alpha 1-adrenergic agonists, phenylephrine and methoxamine, mimic the effects of NE, whereas isoproterenol, a beta-adrenergic receptor agonist, is ineffective. A wide variety of other agents tested had no specific effect on 32Pi incorporation into PI or PA. Prazosin, a selective alpha 1-receptor antagonist, at a concentration of 0.05 microM inhibits 50% of the stimulation due to NE (100 microM), whereas 1 microM yohimbine, an alpha 2-selective antagonist, is required to achieve the same effect. These results demonstrate the existence of an alpha 1-adrenergic receptor-mediated PI effect in isolated canine cerebral microvessels.</abstract><cop>United States</cop><pub>American Society for Pharmacology and Experimental Therapeutics</pub><pmid>6135151</pmid><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0026-895X
ispartof Molecular pharmacology, 1983-07, Vol.24 (1), p.163-167
issn 0026-895X
1521-0111
language eng
recordid cdi_proquest_miscellaneous_80538644
source MEDLINE; EZB-FREE-00999 freely available EZB journals
subjects Adrenergic alpha-Agonists - pharmacology
Adrenergic alpha-Antagonists - pharmacology
Animals
Brain - blood supply
Capillaries - metabolism
Dogs
In Vitro Techniques
Phosphatidic Acids - metabolism
Phosphatidylinositols - metabolism
Receptors, Adrenergic - physiology
Receptors, Adrenergic, alpha - physiology
title An alpha1-adrenergic receptor-mediated phosphatidylinositol effect in canine cerebral microvessels
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T06%3A04%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=An%20alpha1-adrenergic%20receptor-mediated%20phosphatidylinositol%20effect%20in%20canine%20cerebral%20microvessels&rft.jtitle=Molecular%20pharmacology&rft.au=R%20J%20Zeleznikar,%20Jr&rft.date=1983-07&rft.volume=24&rft.issue=1&rft.spage=163&rft.epage=167&rft.pages=163-167&rft.issn=0026-895X&rft.eissn=1521-0111&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E80538644%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=80538644&rft_id=info:pmid/6135151&rfr_iscdi=true